What is Arcus Biosciences's investing cash flow?

Arcus Biosciences (RCUS) reported investing cash flow of $114M in Q1 2026.

How has Arcus Biosciences's investing cash flow changed year-over-year?

Arcus Biosciences's investing cash flow increased by 256.3% year-over-year, from $32M to $114M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Arcus Biosciences RCUS Investing Cash Flow

Investing Cash Flow at other companies

Bristol-Myers SquibbBMY

-$131M+73.7%

Merck & Co.MRK

-$10.21B-587%

Regeneron PharmaceuticalsREGN

-$428.9M-166%

AbbVieABBV

-$574M+21.9%

ArriVent BioPharma, Inc.AVBP

$3.58M-90.3%

ImmunomeIMNM

-$12.02M-336%

Other financials

Income statement

See full

Revenue$17.0M-39.3%

Operating income-$134.0M-9.8%

Net income-$128.0M-14.3%

EPS (diluted)-$1.02+10.5%

Balance sheet

See full

Cash & equivalents$201.0M+4.7%

Total debt$113.0M+88.3%

Total equity$524.0M-1.3%

Total assets$997.0M-13.8%

Cash flow

See full

Operating cash flow-$138.0M-4.5%

CapEx--100%

Free cash flow-$138.0M-3.8%

Valuation

See full

Market cap$3.54B+226%

Enterprise value$3.46B+275%

P/S15×+7.3×

Profitability

See full

Operating margin-168.6%-52.7pp

Net margin-156.4%-47.5pp

FCF margin-207.2%—

Returns & leverage

See full

Return on equity-70%+8.4pp

Debt / equity0.2×+0.1×

Current ratio4×-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcus Biosciences's investing cash flow?: Arcus Biosciences (RCUS) reported investing cash flow of $114M in Q1 2026.
How has Arcus Biosciences's investing cash flow changed year-over-year?: Arcus Biosciences's investing cash flow increased by 256.3% year-over-year, from $32M to $114M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.